At a glance
ClinicalIndex Comparison RecordN/ACompleted· 6 enrolled
Drug / intervention
CES Therapydevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Cranial Electrotherapy Stimulation (CES) Therapy for PTSD and Anxiety in OEF/OIF Veterans With Mild TBI
The University of Texas Health Science Center at San Antonio·interventional·Posted May 25, 2015·Updated Feb 28, 2018
In Brief
A clinical study evaluating CES Therapy for TBI and 3 related conditions. Completed, enrolled 6 participants across 1 site.
Detailed Summary
The primary aim of this proposed study is to gather preliminary data for CES use in treating PTSD and anxiety symptoms in OEF/OIF Veterans with PTSD and a history of TBI.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTBI, Anxiety, PTSD, Depression
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedMay 2015
Enrollment StartOct 2015
Primary CompletionMay 2016
TodayJul 2026
First PostedMay 25, 2015
Enrollment StartOct 1, 2015
Primary CompletionMay 1, 2016
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 11.1 years ago
Interventions
CES Therapydevice
Cranial Electrotherapy Stimulation (CES) may serve as an effective complimentary, noninvasive/non-pharmacological treatment for this Veteran population. CES is administered through a therapeutic device (such as Alpha-Stim®) marketed and approved by the FDA to treat insomnia, depression, anxiety, and pain.